Onconetics Pharmaceuticals, Inc.

Developing gene therapies to target tumor cells with specific gene expression profiles

Company Details

Onconetics Pharmaceuticals, Inc. is a spinout pharmaceutical company from UCSF developing the next generation of personalized gene therapies for cancers and other genetic disorders. Onconetics combines well-established gene therapy techniques with pioneering research to redefine the future of cancer treatment.

Company People

Gabe Hitchcock

Gabe Hitchcock
COO & Co-Founder

Geoff Sargent

Geoff Sargent
CSO

Luke Gruenert

Luke Gruenert
CEO & Co-Founder

GET IN TOUCH WITH Onconetics Pharmaceuticals, Inc.

Please tell us a little bit about yourself and why you'd like to get connected.

Onconetics Pharmaceuticals, Inc. + SOSV will follow up with you via email.

** If you are interested in investing directly into SOSV's portfolio of privately held companies, or into SOSV's funds, you need to meet the SEC’s criteria for accredited investor status. As an individual, you can qualify as an accredited investor by either (a) having more than $200,000 in annual income for each of the past two years (or $300,000 with your spouse) and a reasonable expectation of earning the same this year or (b) having a net worth of at least $1 million (not including your principal residence). Learn More

You might also be interested in

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.